The US Food and Drug Administration (FDA) has approved AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for self-administration. The approval makes FluMist the only flu vaccine in ...

FluMist, the nasal flu vaccine spray, was approved in September by the U.S. Food and Drug Administration for at-home use starting in fall 2025. Currently, it can only be administered by a healthcare ...

If you have a fear of needles and are nervous about getting the flu shot, you’re not alone. It’s estimated that up to 25% of adults have a strong fear of needles. Enter FluMist, the nasal flu vaccine.

Those looking to protect themselves against the flu this season now have an at-home option. FluMist, the only nasal spray flu vaccine approved by the Food and Drug Administration, is now available for ...

Only influenza vaccine approved for self- or caregiver-administration at home, expanding options for influenza protection WILMINGTON, Del.--(BUSINESS WIRE)-- FLUMIST ® has been approved in the US as ...

Eligible individuals will be able to have the vaccine shipped to their homes for self-administration. The Food and Drug Administration (FDA) has approved at-home self- or caregiver-administration of ...